Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension.

Metabolic syndrome, characterized by a constellation of metabolic abnormalities, including central obesity, insulin resistance, hypertension, and dyslipidemia.

17 окт. 2024 г. · The metabolic syndrome (MetS) is a multiplex modifiable risk factor for cardiovascular disease, type 2 diabetes mellitus and other health outcomes.

Metabolic syndrome (MetS) is a bunch of metabolic defects comprising hypertension, insulin resistance, visceral obesity, fatty liver, and atherogenic ...

This review aims to summarise metabolic syndrome's involvement in diabesity and highlight the link between MS and cardiovascular and neurological diseases.

14 нояб. 2023 г. · Metabolic syndrome (MetS) is a group of medical conditions that increase the risk of cardiovascular disease, stroke, and type 2 diabetes.

Metabolic syndrome is a cluster of related conditions that increases an individual's risk for developing cardiovascular disease and Type 2 diabetes mellitus (T ...

Original Article Associations of the PPARα and Lipoprotein Lipase Enzyme Gene Polymorphisms with Dyslipidemia in Obese and Non-obese Males Intermittent Metabolic... · e-Submission · Instructions to Authors · Aims and Scope

Metabolic Syndrome (MetS) is one of main public health problems of recent years. The presence of MetS significantly increases the risk of diabetes and ... Abstract · Introduction · Recommended forms of...

5 мая 2011 г. · Metabolic syndrome (MetS) is a complex disorder defined by a cluster of interconnected factors that increase the risk of cardiovascular atherosclerotic ...